Analyst Recommendations
40.87 0.33(0.81%)06/28/2024
Avidity Biosciences Inc (RNA)
Avidity Biosciences Inc (RNA)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 11 |
Outperform | 1 |
Overweight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades